Publication Listing for the MeSH term microsatellite instability. Found 10 abstracts

Gray PN, Tsai P, Chen D, Wu S, Hoo J, Mu W, Li B, Vuong H, Lu HM, Batth N, Willett S, Uyeda L, Shah S, Gau CL, Umali M, Espenschied C, Janicek M, Brown S, Margileth D, Dobrea L, Wagman L, Rana H, Hall MJ, Ross T, Terdiman J, Cullinane C, Ries S, Totten E, Elliott AM. TumorNext-Lynch-MMR: A comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome. Oncotarget. 2018 Apr 17;9(29):20304-22.   PMCID: PMC5945525

Tricarico R, Kasela M, Mareni C, Thompson BA, Drouet A, Staderini L, Gorelli G, Crucianelli F, Ingrosso V, Kantelinen J, Papi L, De Angioletti M, Berardi M, Gaildrat P, Soukarieh O, Turchetti D, Martins A, Spurdle AB, Nystrom M, Genuardi M, InSi GH. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants. Hum Mutat. 2017 Jan;38(1):64-77.

Zijoo R, Olszanski AJ, Weinberg DS. Biomarkers and stage II colorectal cancer therapy. Translational Cancer Research. 2016 Jun;5:S84-S86.   PMCID: Editorial

Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer. 2012 May;118(9):2532-40.   PMCID: PMC3235256

Rosen DG, Cai KQ, Luthra R, Liu JS. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. MODERN PATHOLOGY. 2006 Nov;19(11):1414-20.

Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends in Endocrinology and Metabolism. 2004 Jul;15(5):211-4.

Ferry KV, Fink D, Johnson SW, Nebel S, Hamilton TC, Howell SB. Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochemical pharmacology. 1999 Apr 15;57(8):861-7.

Zekri AR, Bahnassi AA, Bove B, Huang YJ, Russo IH, Rogatko A, Shaarawy S, Shawki OA, Hamza MR, Omer S, Khaled HM, Russo J. Allelic instability as a predictor of survival in Egyptian breast cancer patients. International Journal of Oncology. 1999 Oct;15(4):757-67.

Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts. Cancer Research. 1998 Aug 15;58(16):3579-85.

Yang XQ, Russo IH, Huang YJ, Russo J. Microsatellite instability of D17S513 on chromosome 17 is associated with progression of breast cancer. International Journal of Oncology. 1997 Jul;11(1):41-6.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

microsatellite instability colon-cancer carcinomas mismatch repair deficiency heterozygosity mutations in-situ Lynch syndrome prognostic factors and AE are all employees of Ambry Genetics MJ is a paid consultant for Ambry identification tumor-development Pathology cisplatin drug-resistance trial lynch-syndrome D17S513 mortality lymph-nodes guanylyl cyclase-c homolog breast epithelial cells breast cancer Genetics nonpolyposis colorectal-cancer colorectal cancer cells resistance recognition transcription in-vitro regions hMLH1 ovarian carcinoma micrometastases immunohistochemistry genes brca2 splicing african-americans survival mammalian-cells tumors human adducts tissue microarrays region chromosome 13q12-q13 prognosis breast epithelial-cells multifactorial analysis DNA mismatch repair allelic imbalance tumor-suppressor gene cancer gene molecular markers chromosome 17 ovarian-cancer cells carcinoma drug resistance functional assays phenotype race tolerance tumor-cells tumor suppressor genes human mismatch repair carrier-ligand neoplastic phenotypes polymerase-delta mismatch repair cancer patients fluorouracil socioeconomic-status kras poor-prognosis tumor- breast carcinomas nucleotide-excision-repair receptor-alpha beta Variants of Uncertain Significance (VUS) colorectal cancer racial disparities-molecular staging-occult tumor burden-guanylyl cyclase C-RT-qPCR er-alpha hMSH2 leucovorin next generation sequencing excision-repair ovarian-